Skip to main content
TipRanks
Go Ultimate75% OFF

Extendicare (0S9E) Share Price & Analysis

2 Followers

0S9E Stock Chart & Stats

CA$29.19-CA$1.10(-3.63%)
At close: 4:30 PM GMT
C$28C$30C$32Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
CAD 29.19 - CAD 30.06
52-Week Range
CAD 19.85 - CAD 39.00
Previous Close
CAD 30.29
Volume
N/A
Average Volume (3M)
247
Market Cap
CAD 2.87B
Enterprise Value
CAD 3.40B
Total Cash (Recent Filing)
CAD 75.26M
Total Debt (Recent Filing)
CAD 590.39M
Price to Earnings (P/E)
21.5
Beta
-0.04
Next Earnings
Mar 04, 2027 (Est.)
Dividend Yield
1.71%

Bulls Say, Bears Say

Bulls Say

Improving Revenue And Profitability

The company has established a multi-period improvement in revenue and operating profitability, providing evidence of strengthening execution rather than a single-quarter benefit. Continued earnings growth can support reinvestment, debt reduction, and service expansion across its care platform over the next several quarters.

CBI Acquisition And Integration Upside

CBI is outperforming its initial underwriting while integration remains on schedule, creating a tangible platform for operating leverage. Completing systems and frontline integration should improve coordination and capture identified synergies, supporting recurring earnings growth beyond the acquisition’s initial contribution.

Structural Demand And Growth Pipeline

Aging demographics, unmet care needs, and a persistent shortage of long-term-care beds provide structural support for demand across Extendicare’s services. This backdrop, combined with new homes and a broad acquisition pipeline, gives the company multiple avenues to expand volumes over the medium term.

Bears Say

Higher Leverage And Balance-sheet Sensitivity

The rise in debt relative to equity increases sensitivity to earnings volatility and financing conditions, even though recent liquidity and deleveraging have improved. Greater leverage can constrain capital allocation and reduce flexibility if operating performance weakens or investment requirements increase.

Weak And Volatile Cash Conversion

Positive operating cash flow has not consistently translated into strong free cash flow relative to reported earnings. Modest and historically volatile conversion may limit internally funded growth, debt reduction, and shareholder distributions, making sustained cash generation an important medium-term execution requirement.

Home Health Margin And Funding Uncertainty

Home health growth is attractive, but margin durability depends on funding increases keeping pace with wage inflation and absorbing technology and back-office investments. Delayed or uncertain Ontario rate actions could keep pressure on profitability even as volumes continue to expand.

Extendicare News

0S9E FAQ

What was Extendicare’s price range in the past 12 months?
Extendicare lowest share price was C$19.85 and its highest was C$39.00 in the past 12 months.
What is Extendicare’s market cap?
Extendicare’s market cap is C$2.87B.
When is Extendicare’s upcoming earnings report date?
Extendicare’s next earnings report is estimated for Mar 04, 2027 (not yet confirmed), which is in 106 days.
How were Extendicare’s earnings last quarter?
Extendicare released its earnings results on Nov 05, 2026. The company reported C$0.354 earnings per share for the quarter, missing the consensus estimate of C$0.355 by -C$0.001.
Is Extendicare overvalued?
According to Wall Street analysts Extendicare’s price is currently Undervalued.
Does Extendicare pay dividends?
Extendicare pays a monthly dividend of C$0.044 which represents an annual dividend yield of 1.71%. See more information on Extendicare dividends here
What is Extendicare’s EPS estimate?
Extendicare’s EPS estimate is 0.36.
How many shares outstanding does Extendicare have?
Extendicare has 95,046,400 shares outstanding.
What happened to Extendicare’s price movement after its last earnings report?
Extendicare reported an EPS of C$0.354 in its last earnings report, missing expectations of C$0.355. Following the earnings report the stock price went down -3.983%.
Which hedge fund is a major shareholder of Extendicare?
Currently, no hedge funds are holding shares in GB:0S9E
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology